Quantification of plasma mutant calreticulin for diagnosis and therapeutic response assessment of peginterferon-α in myeloproliferative neoplasms: A proof-of-concept study
- DOI
- 10.1016/j.cca.2025.120817
- Published
- 2026-02
- Container
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.cca.2025.120817,
title = {Quantification of plasma mutant calreticulin for diagnosis and therapeutic response assessment of peginterferon-α in myeloproliferative neoplasms: A proof-of-concept study},
author = {Jingjing Tian and Xuemei Tang and Weiyan Zhou and Can Yang and Qingyun Zhang and Quanli Wu and Xiaotong Ma and Gusheng Tang and Ming Guan and Zhiyuan Wu},
year = {2026},
journal = {Clinica Chimica Acta},
doi = {10.1016/j.cca.2025.120817},
url = {https://doi.org/10.1016/j.cca.2025.120817}
}RIS
TY - JOUR TI - Quantification of plasma mutant calreticulin for diagnosis and therapeutic response assessment of peginterferon-α in myeloproliferative neoplasms: A proof-of-concept study AU - Jingjing Tian AU - Xuemei Tang AU - Weiyan Zhou AU - Can Yang AU - Qingyun Zhang AU - Quanli Wu AU - Xiaotong Ma AU - Gusheng Tang AU - Ming Guan AU - Zhiyuan Wu PY - 2026 JO - Clinica Chimica Acta DO - 10.1016/j.cca.2025.120817 UR - https://doi.org/10.1016/j.cca.2025.120817 ER -
APA
Tian, J., Tang, X., Zhou, W., Yang, C., Zhang, Q., Wu, Q., Ma, X., Tang, G., Guan, M., & Wu, Z. (2026). Quantification of plasma mutant calreticulin for diagnosis and therapeutic response assessment of peginterferon-α in myeloproliferative neoplasms: A proof-of-concept study. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2025.120817
Source records
- crossref · retrieved 2026-09-26T21:20:57.445Z